Oncolytics Biotech (R) to Host Conference Call to Discuss Co-Development Agreement with Pfizer and Merck KGaA
SAN DIEGO, CA, and CALGARY, AB / ACCESSWIRE / June 5, 2019 / Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC),...
user
Hemogenyx Pharmaceuticals PLC Announces CDX Antibody is Effective against AML in vivo
LONDON, UK / ACCESSWIRE / June 5, 2019 / Hemogenyx Pharmaceuticals plc (LSE: HEMO) announces the first data results from...
Angle PLC Announces Completion of Ovarian Cancer Pre-Study
ANGLE plc ("the Company") SUCCESSFUL COMPLETION OF OVARIAN CANCER PRE-STUDY Pre-study demonstrates ANGLE's optimised sample-to-answer molecular solution with patient samples...
Evotec And Celgene Further Expand Ipsc Collaboration Including New Cell Type
INCLUDING NEW CELL TYPES SUPPORTS DISCOVERY OF DISEASE-MODIFYING THERAPIES FOR NEURODEGENERATIVE DISEASES TRIGGERS $ 9.0 M PAYMENT TO EVOTEC HAMBURG,...
NervGen Pharma Corp. to Present at the 9th Annual LD Micro Invitational
LOS ANGELES, CA / ACCESSWIRE / June 4, 2019 / NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a regenerative medicine...
BridgeHead Software Honored with 2nd Consecutive “MedTech Breakthrough Award”
Annual Awards Program Recognizes Outstanding Digital Health & Medical Technology Products and CompaniesASHTEAD, UK – June 4, 2019 – BridgeHead...
Milestone Scientific Announces Conversion of Convertible Preferred Stock at $1.17 per Share
LIVINGSTON, NJ / ACCESSWIRE / June 4, 2019 / Milestone Scientific Inc. (NYSE American: MLSS) today announced that the shares...
Aytu BioScience Announces Exclusive Distribution Agreement with Beijing Dahua Sanxin Technology Development Co., Ltd. to Commercialize MiOXSYS(R) Male Infertility Test in China
Initial Purchase by Beijing Dahua Sanxin Technology Development Co., Ltd. Represents First MiOXSYS Commercial Sale in China. ENGLEWOOD, CO /...
ReShape Lifesciences Strengthens Executive Leadership Team with Appointment of Kevin Condrin as Senior Vice President of Commercial
SAN CLEMENTE, CA / ACCESSWIRE / June 4, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
Avinger Announces Distribution Agreement for Hong Kong
Expands Market Presence in Asia Pacific Region REDWOOD CITY, CA / ACCESSWIRE / June 4, 2019 / Avinger, Inc. (NASDAQ:...
Arcutis Announces Initiation of Phase 2a Clinical Trial of ARQ-151 as a Potential Topical Treatment for Atopic Dermatitis
ARQ-151 Potential "Best in Class" Topical PDE4 inhibitor ARQ-151 is 50- to 300-fold more potent than approved PDE4 inhibitors Phase...
Ozop Surgical Corp Announces Progress on New Spine Implant
Designed and Engineered to Speed Surgery and Provide Patient Optimized Fit WEST PALM BEACH, FL / ACCESSWIRE / June 3,...
Dr. Nikesh Seth Supports Students Pursing Post-Secondary Education in Healthcare and Medicine
A double board-certified Anesthesiologist, Dr. Nikesh Seth is also CEO of Integrated Pain Consultants with three locations in Arizona; Consistently...
NanoVibronix Announces Planned Launch of CBD Patch and Cream for PainShield(R) Designed to Amplify Therapeutic Effect
- Combination of nanoparticle CBD-infused patch/cream and PainShield® intended as powerful alternative to opioids for treatment of pain - NanoVibronix...
Medical Research Collaborative, LLC Announces Launch of Website Offering Market Research on the Global Healthcare Sector
ST. PETERSBURG, FL / ACCESSWIRE / June 3, 2019 / Medical Research Collaborative, LLC (MRC) announces the recent launch of...
ENDRA Life Sciences Appoints Renaud Maloberti as Chief Commercial Officer
20-Year Global Commercial Medical Imaging Veteran to Lead Rollout of ENDRA Technology in European and U.S. Markets ANN ARBOR, MI...
Virpax(R) Pharmaceuticals Selected for Two Presentations at the 2019 Military Health System Research Symposium
MALVERN, PA / ACCESSWIRE / June 3, 2019 / Virpax® Pharmaceuticals, Inc. ("Virpax"), a company specializing in developing pharmaceutical products...
Jaguar Health Refinances $10.5 Million of Secured Debt, Including an Extension of the Maturity of Such Debt from December 31, 2019 to December 31, 2020
SAN FRANCISCO, CA / ACCESSWIRE / June 3, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a...
Heat Biologics Announces Promising Interim Phase 2 Lung Cancer Data Suggesting that HS-110 Plus Nivolumab May Restore Clinical Benefit After Checkpoint Inhibitor Treatment Failure
Clinical benefit observed in 55% of patients receiving HS-110 plus nivolumab after checkpoint inhibitor treatment failureHS-110 in combination with nivolumab...
EyeGate Receives Approval from FDA to Initiate PRK Pivotal Study
WALTHAM, MA / ACCESSWIRE / June 3, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) ("EyeGate" or "the Company") announced today...